GDF11 against aging
How Elevian is tackling age-related diseases with GDF11
Harvard University spinout Elevian Inc. is developing a regenerative platform around GDF11 to treat age-related diseases, including Alzheimer's disease. The company, which emerged from stealth on Sept. 6, aims to modulate the protein’s pathway with antibodies, small molecules, or recombinant versions of the protein itself.
GDF11, part of the transforming growth factor β (TGFβ) family, affects cellular growth and development; and GDF deficiency in mice causes